When the Grammy-nominated singer-songwriter Aloe Blacc After he got COVID despite vaccination and vaccination, he tried to fund research for a better solution. What did he immediately realize? You can’t just write checks in biotech. Regulators require a commercialization plan, and philanthropy doesn’t advance science through clinical trials or get you a license on university IP. Now, he is bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that kills 90% of its patients, and is deliberately waiting to grow from his network until peer-reviewed papers make his case.
Watch Aloe Blacc join Rebecca Bellon on TechCrunch equity Podcast to talk about what happens when a creator decides to create instead of just invest, how Elo is watching AI reshape both the biotech and music industries in real time, and his thoughts on who really wins.
subscribe equity youtube, apple podcast, overcast, spotify And all castes. You can also follow equities x And threadsOn @EquityPod.
